Dapsone-Associated Hemolytic Anemia in Renal Transplant Recipients With Normal Glucose-6-Phosphate-Dehydrogenase Levels
- PMID: 32947344
- DOI: 10.1097/MJT.0000000000001252
Dapsone-Associated Hemolytic Anemia in Renal Transplant Recipients With Normal Glucose-6-Phosphate-Dehydrogenase Levels
Conflict of interest statement
The authors have no conflicts of interest to declare.
References
-
- Brakemeier S, Pfau A, Zukunft B, et al. Prophylaxis and treatment of Pneumocystis Jirovecii pneumonia after solid organ transplantation. Pharmacol Res. 2018;134:61–67.
-
- Podzamczer D, Salazar A, Jimenez J, et al. Intermittent trimethoprim compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patient infected with HIV. Ann Intern Med. 1995;122:755–761.
-
- Plotkin JS, Buell JF, Njoku MJ, et al. Methemoglobinemia associated with dapsone treatment in solid organ transplant recipients: a two-case report and review. Liver Transpl Surg. 1997;3:149–152.
-
- Lee SM, Geetha D. Dapsone induced hemolysis in a patient with ANCA associated glomerulonephritis and normal G6PD level and implications for clinical practice: case report and review of the literature. Springerplus. 2015;4:29.
-
- Gryzan S, Paradis IL, Zeevi A, et al. Unexpectedly high incidence of Pneumocystis carinii infection after lung– heart transplantation. Implications for lung defense and allograft survival. Am Rev Respir Dis. 1988;137:1268–1274.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical